PreveCeutical Medical (TSE:PREV) has released an update.
PreveCeutical Medical Inc. has secured $297,731 in interest-free, unsecured loans from key insiders, including CEO Stephen Van Deventer, to bolster its working capital. The company, specializing in preventive health sciences, is directing the funds toward the continued development and eventual commercialization of its health products. These strategic financial moves come as part of PreveCeutical’s efforts to progress in its innovative health solution research programs.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
